Drug interactions
Dichlorphenamide + Pasireotide
Severity: Moderate
Dichlorphenamide and Pasireotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pasireotide prolongs the QT interval, and hypokalemia from dichlorphenamide increases the risk of torsades de pointes. The combination therefore raises arrhythmia risk.
What this interaction means in plain words
Dichlorphenamide and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dichlorphenamide belongs to Miscellaneous; Pasireotide belongs to Endocrine.
Why it happens
Dichlorphenamide-induced hypokalemia potentiates the QT-prolonging effect of pasireotide (pharmacodynamic).
What to do
Correct hypokalemia before and during pasireotide therapy, monitor potassium regularly, and obtain ECGs as indicated.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Pasireotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dichlorphenamide
Other interactions of Pasireotide
- Dronedarone + Pasireotide Contraindicated
- Pasireotide + Pimozide Contraindicated
- Amiodarone + Pasireotide Major
- Amisulpride + Pasireotide Major
- Amitriptyline + Pasireotide Major
- Anagrelide + Pasireotide Major
Frequently asked questions
Can I take Dichlorphenamide with Pasireotide?
MediHelp rates the interaction as moderate. Dichlorphenamide and Pasireotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide prolongs the QT interval, and hypokalemia from dichlorphenamide increases the risk of torsades de pointes. The combination therefore raises arrhythmia risk.
How serious is the interaction between Dichlorphenamide and Pasireotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Correct hypokalemia before and during pasireotide therapy, monitor potassium regularly, and obtain ECGs as indicated.
What other medicines interact with Dichlorphenamide?
MediHelp also lists interactions of Dichlorphenamide with, for example, Acetazolamide, Acetylsalicylic acid, Ammonium chloride. The full list is on the Dichlorphenamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
